DK1163904T3 - Sammensætning til forebyggelse af glat muskelsygdom, der omfatter ascorbat, arginin og magnesium - Google Patents
Sammensætning til forebyggelse af glat muskelsygdom, der omfatter ascorbat, arginin og magnesiumInfo
- Publication number
- DK1163904T3 DK1163904T3 DK00112811T DK00112811T DK1163904T3 DK 1163904 T3 DK1163904 T3 DK 1163904T3 DK 00112811 T DK00112811 T DK 00112811T DK 00112811 T DK00112811 T DK 00112811T DK 1163904 T3 DK1163904 T3 DK 1163904T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- composition
- smooth muscle
- ascorbate
- arginine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title 2
- 239000004475 Arginine Substances 0.000 title 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 title 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title 1
- 208000029578 Muscle disease Diseases 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- 229940072107 ascorbate Drugs 0.000 title 1
- 235000010323 ascorbic acid Nutrition 0.000 title 1
- 239000011668 ascorbic acid Substances 0.000 title 1
- 229910052749 magnesium Inorganic materials 0.000 title 1
- 239000011777 magnesium Substances 0.000 title 1
- 210000002460 smooth muscle Anatomy 0.000 title 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 208000009205 Tinnitus Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 231100000886 tinnitus Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00112811A EP1163904B1 (en) | 2000-06-16 | 2000-06-16 | Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1163904T3 true DK1163904T3 (da) | 2006-08-14 |
Family
ID=8168995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00112811T DK1163904T3 (da) | 2000-06-16 | 2000-06-16 | Sammensætning til forebyggelse af glat muskelsygdom, der omfatter ascorbat, arginin og magnesium |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1163904B1 (zh) |
JP (1) | JP2002047183A (zh) |
KR (1) | KR100793573B1 (zh) |
CN (1) | CN1245973C (zh) |
AT (1) | ATE323479T1 (zh) |
AU (1) | AU780906C (zh) |
BR (1) | BR0103256A (zh) |
CA (1) | CA2350713C (zh) |
CZ (1) | CZ20012178A3 (zh) |
DE (1) | DE60027415T2 (zh) |
DK (1) | DK1163904T3 (zh) |
ES (1) | ES2258426T3 (zh) |
HK (1) | HK1043947A1 (zh) |
HU (1) | HUP0102489A2 (zh) |
IL (1) | IL143697A (zh) |
NO (1) | NO20013004L (zh) |
PL (1) | PL348097A1 (zh) |
PT (1) | PT1163904E (zh) |
RU (1) | RU2280441C2 (zh) |
SK (1) | SK285454B6 (zh) |
TR (1) | TR200101673A2 (zh) |
UA (1) | UA77147C2 (zh) |
ZA (1) | ZA200104931B (zh) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60027415T2 (de) * | 2000-06-16 | 2006-10-19 | Rath, Matthias, Dr.med. | Zusammensetzung für die Verhinderung der Glattmuskelkrankheiten, die Ascorbat, Arginin und Magnesium enthält |
US6576634B1 (en) * | 2000-07-07 | 2003-06-10 | N.V. Nutricia | Pharmaceutical or dietetic preparation for improvement of fertility and sperm quality |
US6372264B1 (en) * | 2000-08-24 | 2002-04-16 | Gusty Winds Corporation | Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium |
CA2422819C (en) * | 2000-09-22 | 2008-07-08 | Mars Uk Limited | Food supplement |
UA77660C2 (en) | 2000-10-03 | 2007-01-15 | Compositions and methods for reducing plasma lipoprotein a level in human | |
AU2003239154B2 (en) * | 2002-01-31 | 2007-02-01 | Chemstop Pty Ltd | Process for the preparation of a nutrient formulation |
AUPS019802A0 (en) * | 2002-01-31 | 2002-02-21 | Chemstop Pty Ltd | Nutrient formulation |
GB0202900D0 (en) | 2002-02-07 | 2002-03-27 | Laxdale Ltd | Novel formulations of drugs |
CA2486881A1 (en) * | 2002-05-20 | 2003-11-27 | Chemstop Pty Ltd | Process for the preparation and activation of substances and a means of producing same |
ATE464043T1 (de) * | 2002-08-22 | 2010-04-15 | Vasopharm Biotech Gmbh | Pharmazeutische zusammensetzung enthaltend l- arginin |
US9655966B2 (en) * | 2002-08-28 | 2017-05-23 | Kedar N. Prasad | Micronutrient formulations for radiation applications |
WO2004069822A1 (ja) * | 2003-02-05 | 2004-08-19 | Santen Pharmaceutical Co., Ltd. | ステロイド副作用抑制組成物 |
CA2833559A1 (en) * | 2003-02-14 | 2004-09-02 | Children's Hospital & Research Center At Oakland | Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
EP1628658A4 (en) * | 2003-05-30 | 2007-09-05 | Matthias Rath | FUNCTIONAL COMPOSITION AND METHOD FOR INHIBITING CONTRACTION OF SMOOTH MUSCLE CELLS |
WO2005094770A1 (en) * | 2004-03-30 | 2005-10-13 | Unilever Plc | Skin lightening compositions comprising vitamines and flavonoids |
FR2884691B1 (fr) * | 2005-04-21 | 2007-07-20 | Formquest Ltd | Complement alimentaire comprenant une combinaison d'agents antioxydants et d'agents energisants utile comme aide a la fertilite chez l'homme et chez la femme |
FR2884692B1 (fr) * | 2005-04-21 | 2009-08-14 | Formquest Ltd | Complement alimentaire comprenant une association d'agents antioxydants et de carnitine, obtenue par synthese endogene ou exogene, comme aide a la fertilite chez l'homme et chez la femme |
US7754700B2 (en) | 2006-04-24 | 2010-07-13 | Trager Seymour F | Composition and methods for alleviating symptoms of neurotoxicity |
EP1854453B1 (de) * | 2006-05-12 | 2011-02-16 | Verla-Pharm Arzneimittelfabrik Apotheker H.J. von Ehrlich GmbH & Co. KG | Lagerstabile wässrige Zusammensetzungen, umfassend eine Magnesiumverbindung und L-Carnitin |
EP1862163A1 (de) | 2006-05-12 | 2007-12-05 | Verla-Pharm Arzneimittelfabrik Apotheker H.J. von Ehrlich GmbH & Co. KG | L-Carnitin zur Kristallisationsverzögerung |
RU2315612C1 (ru) * | 2006-08-29 | 2008-01-27 | Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" | Средство для лечения заболеваний глаз |
WO2011033884A1 (ja) * | 2009-09-18 | 2011-03-24 | 明治乳業株式会社 | 筋拘縮予防剤 |
AT510810B1 (de) * | 2010-12-09 | 2017-09-15 | Gonadosan Gmbh | Kombinationspräparat zur verbesserung der weiblichen fertilität |
JP2013049670A (ja) * | 2011-08-04 | 2013-03-14 | Fancl Corp | アスコルビン酸製剤 |
EA201790017A1 (ru) * | 2014-06-24 | 2017-06-30 | Дедраф Холдинг Б.В. | Новая минеральная композиция |
CN104688774A (zh) * | 2015-02-17 | 2015-06-10 | 胡梨芳 | 包含手性异构化合物的赖氨酸磷酸氢钙药物组合物及其用途 |
CN105687204B (zh) * | 2016-04-15 | 2018-05-25 | 石家庄东华金龙化工有限公司 | 一种甘氨酸金属螯合物复合物及其制备方法 |
CN106213522A (zh) * | 2016-08-05 | 2016-12-14 | 郑家福 | 营养保健品 |
CN108685754A (zh) * | 2018-07-30 | 2018-10-23 | 郑州兰茜生物工程有限公司 | 一种用于耳鸣及具有健耳舒耳功能的滴耳剂 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5535049A (en) * | 1978-09-04 | 1980-03-11 | Otsuka Pharmaceut Factory Inc | Amino acid transfusion for cancerous patient |
US5650418A (en) * | 1990-06-04 | 1997-07-22 | Therapy 2000 | Therapeutic lysine salt composition and method of use |
US5278189A (en) * | 1990-06-04 | 1994-01-11 | Rath Matthias W | Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A) |
US5198465A (en) * | 1991-06-19 | 1993-03-30 | Dioguardi Francesco S | Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen |
GB2268871A (en) * | 1992-07-04 | 1994-01-26 | Bio Nutritional Health Service | Composition for use as a food or food supplement |
US5891459A (en) * | 1993-06-11 | 1999-04-06 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
US5626883A (en) * | 1994-04-15 | 1997-05-06 | Metagenics, Inc. | Ascorbic acid compositions providing enhanced human immune system activity |
EP0891771A1 (en) * | 1997-07-08 | 1999-01-20 | Health Now, Inc. | Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases |
AU3221599A (en) * | 1998-04-03 | 1999-10-25 | Daily Wellness Company, The | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation |
GB9922751D0 (en) * | 1999-09-27 | 1999-11-24 | Kenton Corp Limited | A pharmaceutical composition for stabilising atherosclerotic plaques |
DE60027415T2 (de) * | 2000-06-16 | 2006-10-19 | Rath, Matthias, Dr.med. | Zusammensetzung für die Verhinderung der Glattmuskelkrankheiten, die Ascorbat, Arginin und Magnesium enthält |
-
2000
- 2000-06-16 DE DE60027415T patent/DE60027415T2/de not_active Expired - Fee Related
- 2000-06-16 AT AT00112811T patent/ATE323479T1/de not_active IP Right Cessation
- 2000-06-16 EP EP00112811A patent/EP1163904B1/en not_active Expired - Lifetime
- 2000-06-16 ES ES00112811T patent/ES2258426T3/es not_active Expired - Lifetime
- 2000-06-16 DK DK00112811T patent/DK1163904T3/da active
- 2000-06-16 PT PT00112811T patent/PT1163904E/pt unknown
-
2001
- 2001-06-12 IL IL143697A patent/IL143697A/en not_active IP Right Cessation
- 2001-06-13 SK SK823-2001A patent/SK285454B6/sk unknown
- 2001-06-13 BR BR0103256-9A patent/BR0103256A/pt not_active Application Discontinuation
- 2001-06-15 RU RU2001116855/15A patent/RU2280441C2/ru not_active IP Right Cessation
- 2001-06-15 TR TR2001/01673A patent/TR200101673A2/xx unknown
- 2001-06-15 CA CA002350713A patent/CA2350713C/en not_active Expired - Fee Related
- 2001-06-15 KR KR1020010033746A patent/KR100793573B1/ko not_active IP Right Cessation
- 2001-06-15 PL PL01348097A patent/PL348097A1/xx unknown
- 2001-06-15 CZ CZ20012178A patent/CZ20012178A3/cs unknown
- 2001-06-15 CN CNB011243309A patent/CN1245973C/zh not_active Expired - Fee Related
- 2001-06-15 JP JP2001181658A patent/JP2002047183A/ja not_active Ceased
- 2001-06-15 ZA ZA200104931A patent/ZA200104931B/xx unknown
- 2001-06-15 NO NO20013004A patent/NO20013004L/no not_active Application Discontinuation
- 2001-06-15 UA UA2001064163A patent/UA77147C2/uk unknown
- 2001-06-15 AU AU51942/01A patent/AU780906C/en not_active Ceased
- 2001-06-15 HU HU0102489A patent/HUP0102489A2/hu unknown
-
2002
- 2002-07-30 HK HK02105586A patent/HK1043947A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA200104931B (en) | 2001-12-20 |
CA2350713A1 (en) | 2001-12-16 |
RU2280441C2 (ru) | 2006-07-27 |
UA77147C2 (en) | 2006-11-15 |
SK8232001A3 (en) | 2002-01-07 |
EP1163904A1 (en) | 2001-12-19 |
CA2350713C (en) | 2007-01-16 |
KR20010113499A (ko) | 2001-12-28 |
SK285454B6 (sk) | 2007-01-04 |
DE60027415T2 (de) | 2006-10-19 |
HK1043947A1 (en) | 2002-10-04 |
KR100793573B1 (ko) | 2008-01-14 |
CZ20012178A3 (cs) | 2002-04-17 |
PL348097A1 (en) | 2001-12-17 |
ES2258426T3 (es) | 2006-09-01 |
JP2002047183A (ja) | 2002-02-12 |
AU5194201A (en) | 2001-12-20 |
BR0103256A (pt) | 2002-03-12 |
AU780906C (en) | 2006-04-27 |
EP1163904B1 (en) | 2006-04-19 |
AU780906B2 (en) | 2005-04-21 |
ATE323479T1 (de) | 2006-05-15 |
DE60027415D1 (de) | 2006-05-24 |
CN1245973C (zh) | 2006-03-22 |
PT1163904E (pt) | 2006-07-31 |
NO20013004D0 (no) | 2001-06-15 |
IL143697A (en) | 2006-12-10 |
CN1333020A (zh) | 2002-01-30 |
TR200101673A2 (tr) | 2002-02-21 |
HUP0102489A2 (hu) | 2003-11-28 |
IL143697A0 (en) | 2002-04-21 |
NO20013004L (no) | 2001-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1163904T3 (da) | Sammensætning til forebyggelse af glat muskelsygdom, der omfatter ascorbat, arginin og magnesium | |
CY1107609T1 (el) | Απεικoνιση, διaγνωση και θεραπεiα ασθeνειας | |
CY1110437T1 (el) | Χρηση παραγωγων καστανοσπερμινης για την θεραπεια της ηπατιτιδας c | |
DK1409544T3 (da) | Humane DR4-antistoffer og anvendelser deraf | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
DK1414486T3 (da) | Anvendelse af GLP-2 i kombination med et andet terapeutisk middel ved knoglerelaterede sygdomme | |
ATE510562T1 (de) | Anti-ailim antikörper zur behandlung von crohn's | |
DK1765388T3 (da) | Kombinationsterapi til forebyggelse eller behandling af alzheimer's sygdom, og kit dertil | |
NO20055941L (no) | Anvendelse av en sammensetning omfattende en PDE4-inhibitor og en PDE5-inhibitor | |
CL2004000639A1 (es) | Compuestos derivados de quinolina y quinoxalina, composicion farmaceutica, combinacion farmaceutica; kit farmaceutico; y su uso para tratar aterosclerosis, enfermedad de arteria coronaria, enfermedad cardiaca coronaria, enfermedad vascular coronaria, | |
DK1670482T4 (da) | Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme | |
DK1793859T3 (da) | Behandling af oral og intestinal mucositis ved indgivelse af humant IL-18 | |
NO20043614L (no) | 2`-halogen-3`,5`-dialkoksyfen-1`-yl-imino-2-imidazolid in-derivater og anvendelse derav for behandling av urin-inkontinens | |
WO2002067951A3 (de) | Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten | |
NO20040815L (no) | Anvendelse av antroquinoner i behandling av nyresykdom. | |
DE60308862D1 (de) | Verbindungen und zusammensetzungen zur behandlung von diabetes und erkrankungen, die mit diabetes in zusammenhang stehen | |
TW200509922A (en) | Methods of therapeutic treatment using amounts of retinoid components | |
CL2004000633A1 (es) | Compuestos copolimeros, composicion farmaceutica que los contiene y procedimiento de preparacion, utiles en el tratamiento de enfermedades metabolicas oseas. | |
UA5430S (uk) | Комплекс лікувально-тренувальний офтальмологічний | |
RU2004107704A (ru) | Способ лечения больных с глубокими ожогами перианальной области | |
SG106614A1 (en) | Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body | |
ITUD20030021A1 (it) | Procedimento per la concia delle pelli e pelli cosi' ottenute. | |
RU2002103753A (ru) | Способ лечения хронических гепатитов B и C | |
UA37798A (uk) | Спосіб лікування вперше виявлених хворих на обмежені форми туберкульозу легень |